Goldman Sachs Group Inc Third Harmonic Bio, Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 221,090 shares of THRD stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
221,090
Previous 157,974
39.95%
Holding current value
$1.19 Million
Previous $548,000
118.98%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding THRD
# of Institutions
103Shares Held
38.4MCall Options Held
62.7KPut Options Held
119K-
Atlas Venture Life Science Advisors, LLC10.4MShares$56 Million12.42% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.78MShares$31.1 Million1.12% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.82MShares$20.6 Million15.71% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.94MShares$15.8 Million0.7% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA1.92MShares$10.3 Million2.12% of portfolio
About Third Harmonic Bio, Inc.
- Ticker THRD
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,328,900
- Market Cap $217M